ABSTRACT ␥-Aminobutyric acid, which is synthesized by two isoforms of glutamate decarboxylase (GAD), inhibits the transfer of nociceptive signals from primary afferent fibers to the central nervous system. However, the roles of a 65-kDa isoform of GAD (GAD65)-mediated GABA in nociceptive processing are less clear. This study tested whether partial reductions in GABAergic inhibitory tone by GAD65 gene knockout [GAD65(Ϫ/Ϫ)] would contribute to the regulation of pain threshold in mice. Experiments were performed on male wild-type (WT) mice and GAD65(Ϫ/Ϫ) mice. Acute nociception and inflammatory pain tests were compared between WT mice and GAD65(Ϫ/Ϫ) mice. GABA A receptor-mediated inhibitory postsynaptic currents were also examined by use of the whole-cell patch-clamp method in somatosensory cortical neurons in brain slices. In the hot plate test, which reflects supraspinal sensory integration, a significant reduction in the latency was observed for GAD65(Ϫ/Ϫ) mice. Intraperitoneal administration of the GABA
ethyl]-1,2,5,6-tetrahydro-3-pyridinecarboxylic acid hydrochloride (C 21 H 22 N 2 O 3 ⅐HCl; NO-711), dose-dependently prolonged the latency in both genotypes, suggesting that GABA concentration contributes to acute thermal nociception. However, there was no genotype difference in responses to the tailimmersion test or the von Frey test, indicating that spinal reflex and mechanical nociception are kept intact in GAD65(Ϫ/Ϫ) mice. There was no genotype difference in responses to chemical inflammatory nociception (formalin test and carrageenan test). Although properties of the phasic component of inhibitory postsynaptic currents were similar in both genotypes, tonic inhibition was significantly reduced in GAD65(Ϫ/Ϫ) mice. These results support the hypothesis that GAD65-mediated GABA synthesis plays relatively small but significant roles in nociceptive processing via supraspinal mechanisms.
The central nervous system contains a pain-modulation system that controls the transmission of nociceptive signals from the periphery to the cerebral cortex. In the spinal cord, pharmacological inhibition of GABA-mediated inhibition in normal rats results in tactile allodynia and thermal hyperalgesia (Malan et al., 2002) , suggesting that reduced GABAergic inhibition contributes to the allodynia and hyperalgesia observed after peripheral nerve injury. In fact, reduced levels of GABA have been reported after axotomy and chronic constriction injury of the sciatic nerve (Castro-Lopes et al., 1993) . Supraspinal GABAergic inhibition also plays an important role in neuronal hyperexcitability of spinal/supraspinal nociceptive neurons. Facilitation of GABAergic inhibition through specific GABA A receptor subtypes at the spinal cord (Malan et al., 2002) and at supraspinal sites (Knabl et al., 2008) should be able to compensate for loss of inhibition, providing a rational basis for the development of GABAergic drugs for the treatment of pain.
In general, two types of inhibitions are mediated by GABA A receptors. A phasic form of GABAergic inhibition (phasic inhibition) regulates neural excitability via the activation of postsynaptic GABA A receptors by intermittent GABA release from presynaptic terminals, whereas a persistent tonic form of GABAergic inhibition (tonic inhibition) is generated by the continuous activation of extrasynaptic GABA A receptors by low concentrations of ambient GABA (Farrant and Nusser, 2005) . Glutamate decarboxylase (GAD) is the only synthetic enzyme responsible for the conversion of L-glutamic acid to GABA. Two forms of GAD have been identified, differing in molecular size, amino acid sequence, antigenicity, and cellular and subcellular locations (Erlander et al., 1991) . The 67-kDa isoform (GAD67) is found mainly in the cell body, whereas the 65-kDa isoform (GAD65) localizes to the nerve terminal and binds reversibly to the membrane of synaptic vesicles. Phasic and tonic GABAergic inhibitions have been shown to regulate neural excitability and sensory processing both in vitro (Ataka and Gu, 2006) and in vivo (Chadderton et al., 2004) .
Although previous evidence has indicated that loss of GABAergic inhibition underlies some forms of chronic pain, the relative contributions of GAD65-mediated GABAergic inhibition to nociceptive reactions in the whole animal are less clear. To address this issue, mice deficient in the 65-kDa isoform of glutamate decarboxylase were used to test the hypothesis that partial but continuous reduction of GABAergic inhibition and resulting changes in tonic inhibition of GAD65(Ϫ/Ϫ) mice contribute to the regulation of pain threshold by use of behavioral and electrophysiological assays. GAD65(Ϫ/Ϫ) mice are viable without apparent anatomical deficits (Kash et al., 1997) . Although levels of GAD67 mRNA and protein are largely unchanged by GAD65 mutation (Asada et al., 1996) , GABA content in the amygdala, hypothalamus, and parietal cortex in GAD65(Ϫ/Ϫ) mice is approximately half of that in wild-type (WT) mice (Stork et al., 2000) . In addition, Kash et al. (1997) have reported that postsynaptic GABA A receptor density is unchanged in GAD65(Ϫ/Ϫ) mice. Given these features, GAD65(Ϫ/Ϫ) mice seem well suited for an analysis of GABA functions. This study first investigated the functional contributions of GAD65(Ϫ/Ϫ) to pain thresholds using behavioral assays. Next, the study examined whether GAD65(Ϫ/Ϫ) would affect phasic and tonic components of GABA A receptor-mediated inhibitory postsynaptic currents (IPSCs) using the whole-cell patch-clamp method in somatosensory cortical neurons.
Materials and Methods
Mice. All animal procedures and protocols used in this study were approved by the Animal Care Committee of Gunma University Graduate School of Medicine (protocol 05-71) and performed according to the National Institutes of Health Guidelines. The generation of GAD65(Ϫ/Ϫ) mice has been described previously (Yanagawa et al., 1999; Yamamoto et al., 2004) . These GAD65(Ϫ/Ϫ) mice were backcrossed to C57BL/6 mice more than 10 times, and then they were used for our experiments. GAD65(Ϫ/Ϫ) mice were viable and fertile, and gross behaviors seemed to be normal without apparent anatomical deficits; however, they exhibited slightly increased anxiety-like behaviors in the open field and elevated zero maze tests and a light/dark avoidance test (Kash et al., 1997; Stork et al., 2000; Kubo et al., 2009) . Adult male WT mice and GAD65(Ϫ/Ϫ) mice used in this study were between 12 and 16 weeks of age and weighed 23 to 28 g. Any mouse that had a seizure during or immediately before a test session was eliminated from the analysis. Genotypes were determined by polymerase chain reaction shortly after weaning. Mice were group-housed (four to six per cage) in a pathogen-free transgenic facility (12-h light/dark cycle; room temperature, 27 Ϯ 2°C), and water and food were available ad libitum. A single experimenter who was blinded to the genotypes of the mice performed the behavioral studies. Mice were kept warm by a heat lamp before and throughout the behavioral experiments to avoid hypothermia. None of the animals was used for more than two experiments and at least 1 week was allowed between the two treatments for the mice to recover.
Behavioral Assays
Hot Plate Test. An animal was placed on an aluminum plate (25 ϫ 20 cm) maintained at 53 Ϯ 0.5°C, and a Plexiglas cage (24 cm in height) was used to restrict the movements of the animal (Hot Plate Analgesia Meter MK-350C; Muromachi Kikai Co., Ltd, Tokyo, Japan). Mice remained on the plate until they performed one of the behaviors regarded as indicative of nociception: hind paw licking and jumping. The latency to responses was measured. Only hind paw responses were used, because forepaw responses are components of normal grooming behavior. To prevent tissue damage, the cutoff latency was set at 60 s in control experiments or 80 s in drug treatment experiments. Animals not responding within the cutoff time were removed and assigned a score of the cutoff time. In these experiments, mice did not show any behavior to conclude that they had been damaged in any way. All measurements were performed between 11:00 AM and 6:00 PM.
Tail-Immersion Test. The spinally mediated nociceptive thresholds were determined by use of a thermoregulated water-circulating pump (NTT-20S; Tokyo Rikakikai Co., Ltd, Tokyo, Japan). The mouse was maintained in a mouse holder, and the distal tail was then immersed in the water bath, which was thermostatically controlled at 48 Ϯ 0.5°C. The tail was rapidly immersed in the bath, and the latency to respond to the heat stimulus with vigorous flexion of the tail was measured to the nearest 0.1 s with use of a manual stopwatch. Animals were removed immediately after responding, and the tail was wiped off with a cloth. The maximal latency allowed was 20 s to prevent tissue damage.
Formalin Test. The test was performed in individual transparent containers. The mice were placed in the test chambers for 30 min. After this adaptation period, 20 l of 5% formalin (dissolved in distilled water) was injected into the dorsal surface of the right hind paw of the mouse using a 30-gauge needle connected to a microsyringe. Each mouse was returned immediately to the observation place after injection. Animal behaviors after formalin injection were recorded continuously by the video recorder for later analysis. The time for which the injected hind paw was lifted, licked, or flinched by the animal was measured for 60 min starting immediately after formalin injection (Dubuisson and Dennis, 1977) .
Carrageenan Test. Injection of -carrageenan (1.0%, 20 l), suspended in normal saline by sonication and injected into the plantar surface of the left hind paw, produces acute, restricted inflammation associated with thermal hyperalgesia and mechanical allodynia (Cunha et al., 2005) . Development of inflammatory pain has been evaluated by monitoring thermal hyperalgesia with a planter test analgesia meter (IITC Life Science Inc., Woodland Hills, CA). The planter analgesia test was performed according to the Hargreaves method (Hargreaves et al., 1988) . After the adaptation period of each animal, tests were performed on the plantar surface by a focused, radiant-heat light source. The light beam was focused to the top of the glass and created a 4 ϫ 6-mm intense spot on the paw. The intensity was adjusted to produce approximately 10-s latency in the thermal planter test. The cutoff time was set at 15 s to avoid tissue damage.
Mechanical von Frey Test. Mechanical sensitivity was assessed with electronic von Frey filaments (electronic anesthesiometer, IITC Life Science Inc.) as reported previously (Cunha et al., 2004) . In a quiet room, mice were placed in acrylic cages (10 ϫ 20 ϫ 24 cm) with wire grid floors 15 to 30 min before the start of experiments. The test consisted of evoking a hind paw flexion reflex with a hand-held force transducer adapted with a sharp polypropylene tip. The investigator was trained to apply the tip perpendicularly to the central area of the hind paw with a gradual increase in pressure. The endpoint was characterized by the removal of the paw followed by clear flinching movements. Triple measurements of paw withdrawal threshold (g) were automatically recorded for each data point.
Thermal Hyperalgesia in GAD65 Knockout Mice
Loss of Righting Reflex. Loss of righting reflex (LORR) was used as a surrogate measure for hypnosis. Each animal was placed on their backs in a chamber (20 ϫ 28 ϫ 15 cm), and the ability to right themselves was observed (Kubo et al., 2009 ). Mice were judged to have lost this reflex when unable to right themselves within 10 s. The time from intraperitoneal injection of the drug to LORR was considered as the latency, and the time between the LORR and the time mice regained the ability to right themselves within 2 s was considered to be the duration of LORR.
Electrophysiology. The methods of brain slice electrophysiology were described previously (Nishikawa and MacIver, 2000; Nishikawa et al., 2005; Ishizeki et al., 2008) . In brief, mice were decapitated under deep isoflurane anesthesia, and the brain was then removed and immediately immersed in a cold (1-4°C) modified Ringer's solution composed of 234 mM sucrose, 2.5 mM KCl, 1.25 mM NaH 2 PO 4 , 10 mM MgSO 4 , 0.5 mM CaCl 2 , 26 mM NaHCO 3 , and 11 mM glucose saturated with 95% O 2 and 5% CO 2 . A block of tissue containing the sensory cortex was quickly dissected out and glued to a DTK-1000 vibratome tray (Dosaka, Kyoto, Japan) with oxygenated, cold-modified Ringer's solution. Slices (500 m) were cut from the brain and then kept in the prechamber (Brain Slice Chamber System; Harvard Apparatus, Holliston, MA) filled with artificial cerebrospinal fluid (ACSF), consisting of 125 mM NaCl, 2.5 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 26 mM NaHCO 3 , 1.25 mM NaH 2 PO 4 , and 11 mM glucose, and bubbled with 95% O 2 and 5% CO 2 at room temperature (22-24°C). Slices were allowed at least 1 h for recovery in the prechamber, which was designed to keep 8 to 12 slices viable for several hours.
Slices were transferred to a recording chamber (1.0 ml in volume, Brain Slice Chamber System; Harvard Apparatus, Inc.) perfused with an oxygenated ACSF at a rate of approximately 3 ml/min. Patch electrodes were made from borosilicate thin-walled capillaries (GDC-1.5; Narishige, Tokyo, Japan). Recording electrodes (5-7 M⍀) were filled with Cs 2 SO 4 -based solution (110 mM Cs 2 SO 4 , 5 mM TEA, 0.5 mM CaCl 2 , 2 mM MgCl 2 , 5 mM EGTA, 5 mM HEPES, and 5 mM MgATP, pH 7.2) to investigate spontaneous IPSCs at a holding potential of 0 mV. Whole-cell patch-clamp recordings were made from visualized layer V pyramidal neurons in the sensory cortex with use of an upright Axioskop2 FS plus microscope (Carl Zeiss GmbH, Jena, Germany). S 1 area was identified by the presence of three to five large (250 -450 m) barrels in layer IV, visible under transillumination. The magnified image was collected by an intensified CCD camera (Hamamatsu Photonics, Hamamatsu, Japan) with contrast enhancement. The image of neurons was displayed on a video monitor, and glass patch pipettes were visually advanced by use of a micromanipulator (MWO3; Narishige, Tokyo, Japan) through the slice to the surface of the neuron. Axopatch 200B amplifier (Axon Instruments Inc., Union City, CA) was used for whole-cell recordings. Whole-cell currents were filtered at 2 to 5 kHz and digitized at 10 kHz (Digidata 1322A; Axon Instruments Inc.) and stored on a Pentium-based PC and article recorder for later analysis. The GABAergic nature of the synaptic currents was verified by applying the GABA A receptor antagonist bicuculline (10 M). In general, series resistances were between 10 and 25 M⍀ and were then compensated approximately 80%. All recordings were performed at room temperature (22-24°C).
Data Analysis. Data acquisition and analysis were performed with pCLAMP software version 8.1 (Axon instruments Inc.) and IGOR Pro version 5.0 (WaveMetrics, Lake Oswego, OR). Synaptic currents were defined as current deflections with a fast rising phase and a relatively slower decay phase. The rise time was defined as the time interval between 10 and 90% of the peak amplitude, and synaptic currents having a rise time of Ͻ2 ms were included for analysis. The amplitude of synaptic current was measured from the initial inflection point (not from the baseline) to the peak to avoid the effects of summation on amplitude distribution. Threshold-level crossings were set at approximately 3-fold of baseline noise, which was measured during the period of no detectable events. As a result, synaptic currents larger than 6 pA in the amplitude were counted for analysis. This definition eliminated the infrequently observed single-channel events or synaptic currents with slow rise time, but successfully detected most IPSCs. The decay phase was fitted with a single exponential curve and a time from peak to 1/e was defined as the decay time constant.
Drugs. NO-711 hydrochloride (Sigma-Aldrich Japan, Tokyo, Japan), a potent and selective GABA transporter 1 inhibitor that crosses the blood-brain barrier, was diluted in sterile saline and injected intraperitoneally 20 min before behavioral assays (hot plate test and tail-immersion test). The intraperitoneally administered drugs were delivered with a volume of 10 l/g body weight. Other drugs were also purchased from Sigma-Aldrich.
Statistics. Results are expressed as mean Ϯ S.D. The results were analyzed by use of Student's t test or one-way analyses of variance (ANOVA). Post hoc comparisons between the individual groups were performed by means of the Tukey test. The level of statistical significance was set at P Ͻ 0.05 in all tests.
Results
Responses to Thermal Nociception in the Hot Plate Test. In the hot plate test, licking or jumping responses were considered to be the result of supraspinal sensory integration (Caggiula et al., 1995; Rubinstein et al., 1996) . To test the sensory performance at the supraspinal level, we first measured the latency to responses from the hot plate set at 53°C (Fig. 1A) . The cutoff latency was set at 60 s. A significant reduction of the latency was observed in GAD65(Ϫ/Ϫ) mice (18.2 Ϯ 4.0 s, n ϭ 20) compared with WT mice (22.1 Ϯ 5.2 s, Fig. 1 . Antinociceptive responses of WT mice and GAD65(Ϫ/Ϫ) mice in the hot plate test (53°C). A, the hot plate test revealed that the latency was significantly reduced in GAD65(Ϫ/Ϫ) mice (n ϭ 20) compared with WT mice (n ϭ 28; ‫,ءء‬ P Ͻ 0.01, Student's t test). Vertical bars represent Ϯ S.D. B, the effects of GABA transporter 1 inhibitor NO-711 on the hot plate test. NO-711 was injected intraperitoneally 20 min before the hot plate test. NO-711 dose-dependently increased the latency in both genotypes (WT, n ϭ 10; GAD65(Ϫ/Ϫ) mice, n ϭ 10; ANOVA, post hoc comparison with the Tukey test). Significant increase in the latency was observed after 3, 6, and 10 mg/kg NO-711 injection in both genotypes; however, there was no genotype difference after NO-711 injection (1, 3, 6, and 10 mg/kg). ‫,ءء‬ P Ͻ 0.01, comparison between genotypes.
n ϭ 28, P Ͻ 0.01), indicating that nociceptive perception via supraspinal sites are increased in GAD65(Ϫ/Ϫ) mice. These results demonstrate that reduced GABAergic inhibitory tone by GAD65(Ϫ/Ϫ) increases supraspinal responses to thermal nociception.
Inhibition of GABA uptake or metabolism is a strategy for enhancing GABAergic inhibitory tone. GABA is cleared from the synaptic cleft by specific, high-affinity, sodium-and chloride-dependent transporters, which are thought to be located on presynaptic terminals and surrounding glial cells. Molecular cloning has revealed the existence of genes for four distinct GABA transporters (termed GAT-1, GAT-2, GAT-3, and BGT-1) (for review, see Borden, 1996) . GAT-1 is responsible for a majority of neuronal GABA transport. We then tested whether the selective GAT-1 inhibitor NO-711 would affect thermal hyperalgesia in GAD65(Ϫ/Ϫ) mice. The cutoff latency was set at 80 s in experiments using NO-711. Animals not responding within 80 s were removed and assigned a score of 80 s. As shown in Fig. 1B , NO-711 dose-dependently increased the latency in the hot plate test in both genotypes (P Ͻ 0.001, at 3.0, 6.0, and 10.0 mg/kg versus control). However, there was no genotype difference in the latency at any dose tested. At high dose (10 mg/kg), the latency reached the cutoff time (80 s) in all of the mice tested (n ϭ 5 each).
Because enhanced GABA concentration by NO-711 may produce hypnotic actions, the latency and duration of LORR was then examined after NO-711 injection. NO-711 did not produce LORR in both genotypes: NO-711 (1 or 3 mg/kg i.p.) had no effect on righting reflex (n ϭ 10 for both genotypes). At high doses (6 mg/kg, n ϭ 6; 10 mg/kg, n ϭ 5), righting reflex was slightly impaired in some mice but observed between 2 and 10 s. These data suggest that GAT-1 inhibitor NO-711 induces a dose-dependent increase in extracellular GABA concentration, and thereby increases the threshold of thermal hyperalgesia without affecting hypnotic properties.
Responses to Thermal Nociception in the Tail-Immersion Test. To test the sensory performance on the spinal level, responses to thermal nociception were examined in the tail-immersion test that reflects spinally mediated reactions (Caggiula et al., 1995) . We measured tail-withdrawal latencies after tail immersion at 48 Ϯ 0.5°C and results are shown in Fig. 2A . There was no significant difference in the latency of the tail-immersion test (WT 6.9 Ϯ 1.6 s versus GAD65(Ϫ/Ϫ) 6.8 Ϯ 1.6 s, n ϭ 14 each). In contrast to the hot plate test, GAT-1 inhibitor NO-711 (3 mg/kg i.p.) had no effect on the tail-immersion test (Fig. 2B) .
Responses to Mechanical Nociception in the von Frey Test. To test the sensory performance on the peripheral level, responses to mechanical nociception were quantified in the mechanical von Frey test (Cunha et al., 2004 ). An electronic anesthesiometer was used to investigate betweengenotype difference in mechanical hypernociception. There was no significant genotype difference (3.2 Ϯ 2.0 g for WT mice, n ϭ 14; 3.2 Ϯ 1.5 g for GAD65(Ϫ/Ϫ) mice, n ϭ 13; Fig.  2C ). The lack of significant effects in the tail-immersion test (Fig. 2, A and B) and the mechanical von Frey test (Fig. 2C) indicates that acute nociception is intact on the spinal and peripheral level in GAD65(Ϫ/Ϫ) mice.
Responses to Chemical Inflammatory Nociception in the Formalin Test. Next, we examined whether the absence of GAD65 affected the behavioral responses of mice in the inflammatory pain model. Inflammatory pain involves an activity-dependent facilitation in excitability of both peripheral neurons (peripheral sensitization), and spinal and supraspinal neurons (central sensitization), including thalamus and cortex. To examine the contribution of GAD65 to inflammatory pain signaling, we used the formalin test: formalin was injected into the hind paw. The subcutaneous injection of formalin (5% formalin, 20 l) produced a well known biphasic pattern of nociceptive behaviors in both genotypes (Fig. 3A) . The nociceptive responses were mainly observed between 0 and 10 min and 10 and 60 min after injection, which corresponds to the early (phase I) and late (phase II) phases. Licking is considered as a nocifensive behavior. Total time of lifting, licking, or flinching in phase I represents a response to chemical nociception due to tissue damage, whereas these responses in phase II are a response to subsequent inflammation. A behaviorally quiescent interphase, where the animals showed very few nociceptive responses, was observed between two phases. No genotype difference was observed in total time of phase I responses (137.7 Ϯ 36.7 s in WT; 134.5 Ϯ 58.9 s in GAD65(Ϫ/Ϫ), n ϭ 10 each). Although no significant genotype difference occurred in phase II responses, phase II responses were often prolonged in GAD65(Ϫ/Ϫ) mice. To detect this difference, we then focused on the later part of phase II (35-60 min; phase 's t test) . B, the effects of GABA transporter 1 inhibitor NO-711 (3 mg/kg) on the tail-immersion test. NO-711 was injected intraperitoneally 20 min before the tail-immersion test. Note that NO-711 (3 mg/kg), which increases the hot plate latency in both genotypes (see Fig. 1B ), has no effect on nociceptive responses in the tail-immersion test (ANOVA, post hoc comparison with the Tukey test). C, the mechanical von Frey threshold is normal in GAD65(Ϫ/Ϫ) mice (Student's t test). Data are presented as mean Ϯ S.D. Fig. 3B , phase IIB responses in GAD65(Ϫ/Ϫ) mice (148.2 Ϯ 75.1 s, n ϭ 10) were significantly longer than those of WT mice (50.6 Ϯ 42.6 s in WT, n ϭ 10, P Ͻ 0.01), whereas no genotype effect was detected in the phase I and phase IIA (10 -35 min). Together, deletion of GAD65 gene and resulting reduction in GABAergic inhibition seems involved in inflammatory pain signaling.
Fig. 2. Antinociceptive responses of WT mice and GAD65(Ϫ/Ϫ) mice in the tail-immersion test and the mechanical von Frey test. A, the tailimmersion test, in which the response is considered to be a spinal reflex, is normal in GAD65(Ϫ/Ϫ) mice (Student

Thermal Hyperalgesia in GAD65 Knockout
Responses to Chemical Inflammatory Nociception in the Carrageenan Test. Based on these data in the formalin test, genotype differences might be expected in models of persistent inflammatory pain. To test this possibility, we then examined responses to carrageenan-induced inflammatory hyperalgesia (Eisenberg et al., 1994) . The paw withdrawal latency of each animal to respond to the thermal stimuli was measured at different time points. The testing of WT mice and GAD65(Ϫ/Ϫ) mice in the planter analgesia test established no significant genotype difference in the latency, although inflammatory hyperalgesia was clearly observed at 6 h after carrageenan injection (n ϭ 9 for both genotypes; Fig.  4A ). The carrageenan injection also significantly decreased the mechanical von Frey threshold 4 to 24 h after injection compared with baseline threshold (n ϭ 5 for both genotypes; Fig. 4B ). However, no significant difference was apparent between genotypes at any time point.
GABA A Receptor-Mediated IPSCs Are Similar in WT Mice and GAD65(؊/؊) Mice. Given these effects of the loss of GAD65 on acute nociception and inflammatory pain in mice, we next tried to provide physiological evidence for the role of GAD65 in central inhibitory synaptic transmission. In the experiments that followed, we tried to identify a functional correlation of deleting GAD65 gene for the phenotype observed in the GAD65(Ϫ/Ϫ) mice. To study inhibitory synaptic transmission, we focused on the somatosensory cortex in brain slices, because the integrated nociceptive information is finally processed and perceived in the primary sensory cortex. Layer V pyramidal neurons receive thalamic input from the main specific sensory relay the ventral posteromedial nucleus and as such are considered to function within the sensory pathway (Deschênes et al., 1994) . Recently, the in vivo whole-cell patch-clamp recording technique has been applied to rat somatosensory cortical neurons (Doi et al., 2007) . Recording neurons, which respond to brush or pinch stimulation of contralateral hind limb, were located between 0.5 and 1.0 mm in the depth from the brain surface (Doi et al., 2007) , suggesting that these neurons are largely layer V pyramidal neurons. Taking these findings into consideration, we then looked at the influence of deleting GAD65 gene on spontaneous GABAergic synaptic currents in sensory cortical neurons (layer V). Action-potential-independent components of GABA A receptor-mediated IPSCs (miniature IPSCs, mIPSCs) were recorded from pyramidal neurons voltage-clamped at 0 mV with use of Cs 2 SO 4 -based internal solutions in the presence of the sodium channel blocker, tetrodotoxin (1 M). Under this condition, mIPSCs were recorded as outward currents and excitatory postsynaptic currents were not detectable because the holding potential of 0 mV is near the reversal potential for excitatory postsynaptic currents. FigFig. 3 . The effects of deletion of GAD65 on the formalin-induced persistent pain. A, the time courses of the formalin-induced nociceptive responses in WT mice (E, n ϭ 10) and GAD65(Ϫ/Ϫ) mice (F, n ϭ 10). Total The time courses of carrageenan-induced thermal (A) and mechanical (B) hyperalgesia in WT mice (n ϭ 9) and GAD65(Ϫ/Ϫ) mice (n ϭ 9). A, note that, after carrageenan injection, the paw withdrawal was significantly decreased at 6 h after injection in the ipsilateral hind paw in both genotypes ‫,ء(‬ P Ͻ 0.05 versus baseline), whereas the latency did not significantly change in the contralateral hind paw. There was no significant genotype difference in paw withdrawal at baseline (WT, 10.2 Ϯ 1.4 s in ipsilateral hind paw and 10.5 Ϯ 2.0 s in contralateral; GAD65(Ϫ/Ϫ) mice, 9.3 Ϯ 1.8 s in ipsilateral hind paw and 9.1 Ϯ 2.2 s in contralateral). B, mechanical hyperalgesia was observed within 4 to 24 h after injection in the ipsilateral hind paw. There was no significant genotype difference in von Frey threshold at baseline (WT, 5.3 Ϯ 1.5 g in ipsilateral hind paw and 4.8 Ϯ 0.9 g in contralateral; GAD65(Ϫ/Ϫ) mice, 5.1 Ϯ 1.5 s in ipsilateral hind paw and 5.6 Ϯ 1.2 s in contralateral). ‫,ءءء‬ P Ͻ 0.001 versus baseline (2, 4, 6, and 24 h in WT mice; 2, 4, and 6 h in GAD65(Ϫ/Ϫ) mice, one-way ANOVA followed by the post hoc Tukey method. Vertical bars represent Ϯ S.D. PWL, paw withdrawal latency. ure 5A shows representative traces of mIPSCs from layer V pyramidal neurons in both genotypes. The amplitude of mIPSCs either displayed as the mean amplitude [13.8 Ϯ 3.6 pA in WT; 12.7 Ϯ 1.8 pA in GAD65(Ϫ/Ϫ); Fig. 5B , top] or as a cumulative probability distribution (Fig. 5B bottom) was unchanged in GAD65(Ϫ/Ϫ) mice. The frequency (Fig. 5C ) and the decay time constant (Fig. 5D ) of mIPSCs were also similar between genotypes, although the frequency showed variations among different recording. Together, these results suggest that the deletion of GAD65 has little effect on the GABA content of spontaneously released synaptic vesicles and on kinetic properties of postsynaptic GABA receptors.
A Tonic Form of GABAergic IPSCs in Pyramidal Neurons Is Reduced in GAD65(؊/؊) Mice. We then examined the influence of GAD65 deletion on a tonic form of GABAergic inhibition of layer V pyramidal neurons in the sensory cortex. Application of bicuculline (10 M) not only abolished mIPSCs, indicating that these currents are solely mediated by GABA A receptors, but also caused a shift of baseline holding currents (Fig. 5E ). The shift of baseline holding currents represents the presence of tonic inhibitory currents mediated by GABA A receptors. The amplitudes of the tonic inhibitory currents revealed by bicuculline were 14.1 Ϯ 5.2 pA in GAD65(Ϫ/Ϫ) mice (n ϭ 10; Fig. 5E ), which were significantly smaller than those of WT mice (21.0 Ϯ 2.9 pA, n ϭ 12, P Ͻ 0.01). After washing out bicuculline, the currents returned to the baseline levels. We observed that the size of tonic inhibitory currents were variable in GAD65(Ϫ/Ϫ) mice. This variability, in part, is due to the variation in GABAergic neuron activity of GAD65(Ϫ/Ϫ) mice, because it has been suggested that the concentration of ambient GABA is an important factor in determining the amplitude of tonic inhibition.
Discussion
Using mice with targeted disruption of the GAD65 gene where GABA synthesis has been partially but chronically impaired (Yanagawa et al., 1999; Shimura et al., 2004; Yamamoto et al., 2004) , we demonstrate that GAD65-mediated GABA synthesis plays significant roles for acute thermal nociception, but not persistent inflammatory pain, and that extracellular GABA concentration is a key regulator of pain threshold in acute thermal nociception. Reduced tonic inhibition in GAD65(Ϫ/Ϫ) mice contributes, at least in part, to genotype difference in acute thermal nociception.
The Role of GAD65 and GAD67 in Neural Inhibition. Two isoforms of the GABA-synthesizing enzyme, GAD65 and GAD67, are regulated differently in terms of expression levels, subcellular localization, and cofactor-dependent activations (Soghomonian and Martin, 1998) . GAD67(Ϫ/Ϫ) mice die soon after birth because of the development of cleft palate, whereas GAD65(Ϫ/Ϫ) mice remain viable and without apparent anatomical deficits (Asada et al., 1996; Kash et al., 1997) . GAD65(Ϫ/Ϫ) mice thus seem well suited for analysis of GABA functions. The failure to induce GAD65-mediated GABA synthesis during postnatal development leads to GABA deficits (averaged 40 -50% of WT levels on average) in the amygdala, hypothalamus, and parietal cortex of adult GAD65(Ϫ/Ϫ) mice (Stork et al., 2000) . As a result of reduced GABA concentrations, GAD65(Ϫ/Ϫ) mice exhibit spontaneous seizures that can be induced by mild stress, leading to reduced survival rates (Kash et al., 1997) . The present study therefore used 12-to 16-week-old male GAD65(Ϫ/Ϫ) mice, with a survival rate of 85 to 90% to this age.
However, it is not clear why two forms of GAD are needed in the central nervous system. Recent evidence indicates that GAD67 is constitutively active and is responsible for the basal GABA production, whereas GAD65 is transiently activated in response to the extra demand of GABA in neurotransmission (Fenalti et al., 2007) . In addition, the presence of smaller molecular weight forms of GAD has been reported either derived from RNA splicing or from proteolytic cleavage of full-length GAD. For instance, 25-and 44-kDa GAD were reported to be derived from GAD67 RNA splicing (Szabo et al., 1994) . In contrast to enzymatically inactive 25-kDa form, the 44-kDa GAD is enzymatically active and has been shown to synthesize GABA (Szabo et al., 1994) . The role of smaller isoforms is largely unknown. Although significant progress has been made in understanding the role of GABA synthesis in the brain, however, further research that extends the in vitro results into in vivo observations are still needed. Neurons were voltageclamped at 0 mV by use of Cs 2 SO 4 -based internal solutions. In this condition, outward currents were mIPSCs recorded from WT mice (top) and GAD65(Ϫ/Ϫ) mice (bottom). The amplitude (B), the frequency (C), and the decay time constant of mIPSCs (D) were compared. Deleting GAD65 had no effect on these parameters (n ϭ 10 for both genotypes). E, a sample trace (upper) shows the shift of baseline holding current after the application of bicuculline (10 M) in layer V pyramidal neuron of GAD65(Ϫ/Ϫ) mice. The lower traces show, at an expanded scale, mIPSCs before and during bicuculline application. The bar graph shows pooled results of baseline shift after the application of 10 M bicuculline (n ϭ 10 for both genotypes; ‫,ءءء‬ P Ͻ 0.01). Bicuculline was applied to the recording chamber for 5 min. 
Thermal Hyperalgesia in GAD65 Knockout
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Extracellular GABA Concentration and Pain Threshold. The pain threshold via GABAergic mechanisms is not always constant, because GABA concentration can be shifted drastically either up or down by various factors. Presynaptic and glial-occupied GATs play a dynamic role in the regulation of extracellular GABA concentration and control of brain excitability by modulating tonic GABAergic inhibition in response to neuronal activity (Richerson and Wu, 2003) . We found that NO-711 greatly prolonged the hot plate latency in both genotypes without affecting LORR (Fig. 1B) , suggesting that the sensitivity of mice to acute thermal pain is influenced by variation in GAT-1 function. GAT-1 plays a predominant role in regulation of extracellular GABA concentration; hence, it can be assumed that GAT-1 modulates the nociceptive threshold via regulating extracellular GABA concentration. In the LORR assay, NO-711 had a minimal effect on the righting reflex, suggesting that hypoalgesia in the hot plate test is unlikely to be caused by motor/hypnotic effects. Consistent with these results, an elevated extracellular GABA level in GAT1-knockout (Xu et al., 2008) or by acute blockade using GAT1-selective inhibitors leads to hypoalgesia in mice, resulting in an overactivation of GABA A receptors responsible for postsynaptic tonic conductance (Jensen et al., 2003) . Together, our data support the hypothesis that GAD65-mediated GABA synthesis plays a significant role in nociceptive processing.
The Effects of GAD65 on Acute Nociceptive Reactions. Significant genotype difference was observed in the hot plate test, but not in the tail-immersion test and mechanical von Frey test. Why does deletion of GAD65 have no effect on spinally and peripherally mediated nociceptive responses? One proposed mechanism is enhanced glycinergic inhibition to compensate reduced GABAergic inhibition in the spinal cord. Because spinal interneurons seem to corelease both GABA and glycine to activate functionally distinct receptors in their postsynaptic target cells (Jonas et al., 1998) , reduced GABAergic transmission in GAD65(Ϫ/Ϫ) mice may produce enhanced glycinergic inhibition via reduced presynaptic tonic inhibition mediated by GABA B receptors (Choi et al., 2008) . If so, it is possible that relatively small reduction in GABAergic inhibition does not affect net inhibitory tone in the spinal cord. To prove this possibility, electrophysiological analysis of inhibitory synaptic transmission at the spinal cord is of interest. Properties of inhibitory synaptic transmission in lamina II and laminae III to IV of the dorsal horn, which are involved in the processing of nociceptive and non-nociceptive sensory information, were compared (Inquimbert et al., 2007) . Fifty-five percent of lamina II neurons received both GABAergic and glycinergic inputs, suggesting that lamina II neurons, which play a crucial role for nociceptive processing, are regulated by glycinergic inhibition. Further examinations are needed to clarify the relative contributions of glycinergic inhibition to acute nociception reactions.
The Effects of GAD65 on Persistent Inflammatory Pain. GAD65(Ϫ/Ϫ) mice showed normal biphasic responses of lifting, licking, or flinching when formalin was injected into the hind paw. GAD65(Ϫ/Ϫ) affected none of these responses in phase I, which are evoked by direct chemical activation of peripheral C-fibers, or the responses in phase II, which depend on local inflammation and/or subsequent sensitization of nociceptive neurons in the spinal dorsal horn (Rosland et al., 1990) . Although there was no significant difference in nociceptive responses in either phase I or II, it still worth noting that phase IIB in the formalin test was significantly prolonged in GAD65(Ϫ/Ϫ) mice. We then assessed whether deletion of GAD65 affects the maintenance of persistent inflammatory pain. Carrageenan-induced thermal/mechanical hyperalgesia was used. Unexpectedly, carrageenan-induced thermal/mechanical hyperalgesia remained intact in GAD65(Ϫ/Ϫ) mice. These results suggest that GAD65-mediated GABA synthesis is not involved in persistent inflammatory pain. It has been shown that prostaglandins, namely prostaglandin E 2 , are key mediators of inflammatory pain sensation and that a specific glycine receptor subtype (GlyR ␣3) is an essential target for spinal prostaglandin E 2 -mediated inflammatory pain sensitization (Harvey et al., 2004) . These data suggest that glycine-mediated inhibitory tone plays an important role for inflammatory pain. In addition, GAD67 may produce more GABA to compensate for the decrease in GABA production due to the loss of GAD65 in the knockout mice. The detailed mechanism for such compensation is currently unknown, and this possibility could not be ruled out.
Electrophysiology. Although a number of cortical and limbic areas play important roles in pain processing, this study focused on pyramidal neurons in the sensory cortex for two reasons. First, the loss of GAD65 was demonstrated to contribute to pain processing at supraspinal levels, but not at the spinal level. Second, the integrated sensory information is finally processed and perceived in the sensory cortex. GABA content in the parietal cortex of GAD65(Ϫ/Ϫ) mice has been shown to be approximately half of that in WT mice (Stork et al., 2000) . To investigate the role of GAD65-mediated GABA on phasic and tonic components of GABAergic synaptic transmission, whole-cell patch-clamp recordings were performed in layer V pyramidal neurons. The frequency and kinetic properties of GABAergic mIPSCs were found to be unaffected by GAD65-knockout (Fig. 5) , indicating that synaptic GABAergic inhibition is essentially normal in GAD65(Ϫ/Ϫ) mice. Only tonic conductance in cortical pyramidal neurons seemed to be smaller in GAD65(Ϫ/Ϫ) mice (Fig. 5) .
How does reduced tonic inhibition correlate with thermal hyperalgesia in mice lacking GAD65? It is difficult to draw any solid conclusion at this stage. Thus, we tentatively propose that genotype difference in tonic conductance may be, at least in part, a cellular basis underlying behavioral differences in acute thermal nociception. However, taking the substantial cell-to-cell variations of tonic current into consideration, it is unlikely that only small genotype difference in tonic conductance explain fully behavioral differences. Although we found that basal inhibitory synaptic transmission of layer V pyramidal neurons was similar in both genotypes, some synaptic connections may still be impaired in GAD65(Ϫ/Ϫ) mice. In fact, these animals have been shown to lack visual cortical long-term depression (Choi et al., 2002) and to exhibit reduced transmitter release in response to sustained stimulation (Tian et al., 1999) . For example, in the hippocampus, the transient increase in the probability of inhibitory transmitter release associated with post-tetanic potentiation was absent in the GAD65(Ϫ/Ϫ) mice (Tian et al., 1999) , suggesting that the size or refilling kinetics of the releasable pool of vesicles are decreased. In this context, the relation between impaired GABA release to sustained stim-ulation and reduced tonic inhibition is of interest in terms of pain sensitivity.
In conclusion, these results support the hypothesis that GABAergic inhibitory tone produced by GAD65 plays relatively small but significant roles in nociceptive processing via supraspinal mechanisms.
